Filing Flows › Lemaitre Vascular (LMAT) › Who owns the stock
Who owns Lemaitre Vascular (LMAT) stock
293 funds reported Lemaitre Vascular (LMAT) shares in their latest 13F filings, worth $2.2B in all. The largest holder is BlackRock ($314M). Last quarter 154 funds added to their stakes and 126 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 3,272,973 | $314M | increase | 2026-06-30 |
| Vanguard Group | 1,622,033 | $132M | increase | 2025-12-31 |
| First Trust Advisors LP | 1,093,502 | $105M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 953,437 | $91.5M | increase | 2026-06-30 |
| State Street | 901,416 | $86.5M | increase | 2026-06-30 |
| Copeland Capital Management, LLC | 924,081 | $76.3M | increase | 2026-09-30 |
| Geode Capital Management, LLC | 788,835 | $75.7M | increase | 2026-06-30 |
| Conestoga Capital Advisors, LLC | 878,581 | $72.6M | decrease | 2026-09-30 |
| Price T Rowe Associates | 755,142 | $72.5M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 604,833 | $58.0M | increase | 2026-06-30 |
| Geneva Capital Management LLC | 589,064 | $56.5M | decrease | 2026-06-30 |
| Dimensional Fund Advisors LP | 493,889 | $47.4M | increase | 2026-06-30 |
| Goldman Sachs Group | 473,194 | $45.4M | increase | 2026-06-30 |
| Invesco | 448,389 | $43.0M | increase | 2026-06-30 |
| Morgan Stanley | 351,083 | $33.7M | decrease | 2026-06-30 |
Lemaitre Vascular's latest quarter
Lemaitre Vascular, Q3 2026: revenue $68.0M (+11% year over year), operating margin 26.0%, net earnings $15.0M, operating cash flow $22.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most LMAT stock?
By the latest 13F filings: BlackRock ($314M); Vanguard Group ($132M); First Trust Advisors LP ($105M); Vanguard Capital Management LLC ($91.5M); State Street ($86.5M).
What is the short interest in LMAT?
1,776,179 shares were sold short at the 2026-10-15 settlement, 2.14% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.